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a b s t r a c t
Genetic information is under constant attack from endogenous and exogenous sources, and the
use of model organisms has provided important frameworks to understand how genome stability
is maintained and how various DNA lesions are repaired. The advance of high throughput next
generation sequencing (NGS) provides new inroads for investigating mechanisms needed for
genome maintenance. These emerging studies, which aim to link genetic toxicology and
mechanistic analyses of DNA repair processes in vivo, rely on defining mutational signatures
caused by faulty replication, endogenous DNA damaging metabolites, or exogenously applied
genotoxins; the analysis of their nature, their frequency and distribution. In contrast to classical
studies, where DNA repair deficiency is assessed by reduced cellular survival, the localization of
DNA repair factors and their interdependence as well as limited analysis of single locus reporter
assays, NGS based approaches reveal the direct, quantal imprint of mutagenesis genome-wide, at
the DNA sequence level. As we will show, such investigations require the analysis of DNA derived
from single genotoxin treated cells, or DNA from cell populations regularly passaged through
single cell bottlenecks when naturally occurring mutation accumulation is investigated. We will
argue that the life cycle of the nematode Caenorhabditis elegans, its genetic malleability combined
with whole genome sequencing provides an exciting model system to conduct such analysis.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/3.0/).
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The use of next generation sequencing allows for defining the
direct consequences of mutagenesis, occurring in response to DNA
alterations, such as DNA adducts, single- and double-strand
breaks or misincorporation of nucleotides, all modulated by the
cellular DNA repair capacity. These emerging studies are based on
a long tradition of using mutagens in model organisms, and
mutagenesis induced by a variety of agents has formed the basis
for unbiased forward genetic screen in yeasts, fruit fly and
http://dx.doi.org/10.1016/j.yexcr.2014.08.011
0014-4827/& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
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C. elegans. Indeed, in 1927 Müller was the first to find that the
exposure of Drosophila germ cells to ionizing irradiation (IR) leads
to increased mutagenesis [1]. Measuring mutagenesis in C. elegans
is facilitated by its life cycle. Worms, which reproduce every 3 to 4
days, are hermaphrodites, containing both male and female germ
cells. Germ cell nuclei can be treated with mutagens, and gametes
derived from these cells fuse to form the zygote. Develop-
ment into a self-fertilizing adult enables clonal amplification of
any quantal DNA damage that was fixed before the zygote divided
(see Fig. 1B). Whole genome sequencing of DNA derived from the
clonal progeny of single worms allows for detecting mutations,
their signatures and distribution. Given that C. elegans is diploid,
individual mutations are expected to occur in 50% of
sequencing reads in the first filial (F1) generation. Working in a
diploid system facilitates survival even with a massive load of
heterozygous mutations. In comparison, classic studies rely on
scoring the number of mutations leading to visible phenotypes, in
the F1 for dominant traits, but more commonly in the F2
generation when recessive traits become visible. The measure-
ment of mutagenesis based on visible mutant counts or by direct
next generation sequencing contrasts with toxicology-based
approaches, where genotoxin treatment leads to reduced germ
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Fig. 1 – Schematics of mutation accumulation in C. elegans grown over generations or following exposure to genotoxic agents.
(A) Several individual progeny of a parental (P0) worm are propagated by self-fertilization for 20 generations, randomly choosing
single L4 larvae each line and generation (F1¼filial generation 1, F20¼filial generation 20). The F20 worm from each line is
expanded to generate sufficient DNA for whole genome sequencing. Mutations (indicated by colored stars) arising at any given
generation have a one in four chance to manifest as homozygous in the following generation. (B) Individual P0 worms are treated
with different doses of genotoxin and allowed to self-fertilize. Three F1 worms, each bearing a number of heterozygous mutations,
are expanded to produce sufficient DNA for whole genome sequencing.
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cell proliferation and or a reduced rate of progeny survival.
Importantly, reduced survival does not necessarily correlate with
DNA repair capacity especially when error prone repair modalities
are used.
When the rate of mutagenesis is low, for instance when
analyzing spontaneous mutagenesis, this is assessing the pace of
evolution; worms have to be propagated for many generations,
typically 20 or more, to obtain a sufficient number of mutations.
C. elegans being hermaphrodites allows for propagation of clonal
lines, the zygote of each generation being the single cell bottle-
neck. Sequencing DNA from the initial parental line and the
last generation, we now know the baseline mutation rate of 1
mutation per generation in C. elegans [2]. This is 3 times higher
than previously reported, and corresponds to 6.71010
per nucleotide per cell division. This is in line with a reported
mutation rate of 3.6109 substitutions per nucleotide per
generation in Saccharomyces cerevisiae [3]. In humans, de novo
mutation rates are dependent on the fathers age at conception
and have been determined as on average 1.20108 per nucleo-
tide per generation for 30 year old fathers [4]. Using previous
estimates of 400 germ cell divisions per generation of for a 30
year old male and 30 for females [5], the average mutation rate
is 0.451010 per nucleotide per germ cell division for the male
lineage.
Mutagenesis is a driving force in tumor progression and both
genetic and environmental factors have been identified to
increase cancer risk. Sequencing of tumor types of varying origin
confirmed a substantial variation in mutation load and mutation
profile, reflective of different cellular origin, environmental expo-
sures or DNA repair deficiencies [6–8]. Indeed, 21 different
mutagenic imprints or mutational signatures, all causing distinct
single nucleotide changes in a preferred sequence context were
recently extracted using a large number of mutations from
over 7000 cancer samples [9]. While some of these mutational
signatures could be assigned to known features of environmental
contributors such as CC4TT dinucleotide substitutions associated
with UV light exposure, predominant C4A mutations with
a transcriptional strand bias suggesting the formation of
bulky adducts on guanine residues indicative of tobacco smoke
exposure, or even signatures of chemotherapy treatment such as
alkylating damage in temozolomide-treated cancers, the etiology
of many base substitution signatures is currently unknown [9].
We know less about causes and events leading to global genome
rearrangements, but discrete signatures are emerging. Chromo-
thripsis refers to massive localized rearrangements, apparently
caused by the fragmentation of a chromosome and the subse-
quent random assembly with copy number gain and loss of
individual chromosomal fragments [10]. In contrast chromoana-
synthesis is defined by clustered rearrangements associated with
copy number gain and is likely caused by replication fork stalling
and template switching [11,12].
The occurrence of mutational signatures upon C. elegans
mutagenesis analogous to those observed in tumor cells, paved
the idea of systematically treating worms with genotoxic agents
and analyzing the frequency and nature of resulting mutational
signatures. Sequencing EMS, ENU and UV/TMP induced mutations
for three decades and extending mutagenesis to a massive scale to
isolate tens of mutants in each gene has provided an in-depth
picture of mutation load and signature. The strong propensity of
EMS to alkylate guanine residues causes a mutation bias of G/C to
A/T transitions, which leads to a higher incidence of stop codons,
thereby increasing the frequency of loss-of-function alleles
[13,14]. In contrast, ENU can modify any of the four nucleotides
with some preference of G/C to A/T transitions and codons are
equally mutable, so non-null alleles are often generated [14,15].
UV/TMP induces base substitution with lower but equal frequency
among all bases; however it preferentially generates small dele-
tion of one to three kilobases [14]. In all cases the occurrence of
large deletions or complex chromosomal rearrangements has not
been systematically investigated by interrogating whole genome
datasets. Treating wild-type and DNA repair defective mutants
with known DNA damaging agents provided a proof of concept
for this approach, and allowed to determine how DNA repair
pathways prevent mutagenesis and contribute to distinct muta-
tional signatures. Treatment with aflatoxin B1, a potent liver
carcinogen, leads to a dose dependent increase in single base
substitutions, with a preponderance for G4T and G4A mutations
in C. elegans analogous to the mutational profile found when
mutated p53 was sequenced from cancer patients with previous
aflatoxin B1 exposure [2,16]. Toxin-induced mutagenesis was
observed with very low doses of aflatoxin B1, not sufficient to
reduce progeny survival, indicating the enormous sensitivity of
this approach. Mutation rates were increased in C. elegans lines
with nucleotide excision repair deficiency, consistent with the
role of this pathway in repairing bulky base lesions [2]. Similarly,
cisplatin treatment, an agent that leads to monoadducts but also
intrastrand and interstrand cross-links, leads to a high rate of
C4A mutations in a CpC context [2]. These mutations increase in
frequency with nucleotide excision repair deficiency, but not with
DNA cross-link or double-strand break repair deficiency, consis-
tent with being the consequence of cisplatin monoadduct
formation.
Propagating C. elegans wild-type and DNA repair mutants over
many generations without exposure to genotoxic agents allows
for assessing which pathways prevent spontaneous mutagenesis
associated with replication failure and endogenous mutagens
(Fig. 1A). The goal of these models is to recapitulate the muta-
tional signatures observed in cancers, and to, by employing a
comprehensive panel of DNA repair mutants, understand how the
cellular repair machinery prevents and at times modulates
mutagenesis. To determine the evolutionary mutation rate and
to address the contribution of different DNA repair pathways to
genome stability, a set of gene deletion lines in components of the
nucleotide excision repair (xpa-1/XPA), base excision repair (ung-
1/UNG), telomere replication (trt-1/TERT, mrt-2/RAD1), apoptosis
(ced-4/APAF1, cep-1/p53), DNA cross-link repair (fcd-2/FANCD2)
and non-homologous end joining (lig-4/LIG4) pathways were
grown for 20 generations [2]. Five lines were propagated in
parallel for each genotype and randomly selected, individual
worms were transferred as a single cell bottleneck each genera-
tion. Interestingly, mutation rates were largely unaltered across
genetic backgrounds over the course of the experiment suggest-
ing robust cellular DNA repair even when one of several DNA
repair pathways was impaired. A previous study, using sequence
analysis across multiple genomic loci in mismatch repair mutants
(msh-2/MSH2, msh-6/MSH6), nucleotide excision repair (xpa-1/
XPA) and base excision repair (nth-1/NTH) mutants indicated a
relative importance of MMR4NER4BER in genome maintenance
under normal growth conditions [17,18]. While an xpa-1-depen-
dent increase in mutation rate and the relative importance of NER
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versus BER was not observed by whole-genome analysis, the
importance of the mismatch repair pathway in correcting replica-
tion errors and polymerase slippage, leading up to a 100 fold
increase in mutation rates has been corroborated in all systems
studied [3,19–21]. In the case of base excision repair (BER), the
effect on genome stability might vary between different gene
deletions due to pathway redundancies, thus requiring further
detailed analysis.
The analysis of lesions associated with defects in the DOG-1/
FANCJ helicase provides a most elegant use of C. elegans classical
genetics and NGS sequencing to analyze how combinations of
repair factors affect mutagenesis. DOG-1 was initially uncovered
as a C. elegans mutation that causes an increased frequency of
mutations. In a first seminal paper Cheung et al found that such
mutations preferably affect loci of G-rich sequences with the
potential to form G-quadruplexes (G4) [22]. In G4 structures
guanines stack into stable, four-stranded secondary structures.
Such structures can impede replication fork progression and are
prone to induce deletions. In dog-1 mutants, most deletions were
in the range of 50 to 300 bp [22,23]. Functional conservation has
been shown for human FANCJ; in vitro studies confirmed FancJ
DNA helicase activity in resolving G4 DNA sequences and a bias
towards deletions in G-rich DNA regions has been observed in
FA-J patient cell lines [24,25]. Inactivation of several DNA repair
genes, including him-6/BLM, xpf-1/XPF or rad-51/RAD51 in a dog-1
mutant background increased the deletion frequency but did not
alter deletion sizes and breakpoint sequences as observed by
sequencing of a small number of deletion products upon PCR
amplification [26]. Using a more powerful reporter system that
allowed for visual selection of deletions at recombinant G4 DNA
sequences stably integrated into the genome, Koole et al. were
able to isolate over 100 dog-1-induced deletions [23]. Deletions
were remarkably uniform in size distribution, ranging from 50 to
300 bp and the breakpoints of deletions, which were not asso-
ciated with additional, inserted DNA sequences, contained mini-
mal breakpoint sequence homology, largely comprised of a single
nucleotide [23]. Similar deletions became evident throughout the
genome upon NGS sequencing of dog-1 mutants propagated for
50 generations and, albeit not focused on any discernable
sequence motive, accumulate in polh-1; polk-1 double mutant
worms [19,23]. C. elegans POLH-1 and POLK-1 are homologs of the
human DNA polymerase eta/POLH and kappa/POLK, respectively,
error prone translesion synthesis polymerases that read past
damaged bases. Intriguingly, deletion of polq-1, the C. elegans
polymerase theta/POLQ homologue, in dog-1 single and polh-1;
polk-1, double mutants leads to much larger 45 kbp deletions
and the absence of any microhomology at the breakpoint [19,23].
These results indicate a function of polymerase theta/POLQ in the
repair of genomic DNA lesions arising at genomic sites such as
G-rich sequences, generating an imprint of DNA repair of 50 to
300 bp deletions. The presence of single base nucleotide homology
at the breakpoint suggests POLQ might stabilize structures, where
upon DNA double-strand processing, resected 30 prime single-
strand overhangs base pair at their complementary terminal
nucleotide (Fig. 2A). Annealing is likely followed by DNA synthesis
and DNA ends are ligated in an alternative end-joining pathway
independent of non-homologous end-joining proteins (Fig. 2A).
Interestingly, some polq-1-dependent deletions contain insertions
of DNA sequences “templated” from adjacent DNA regions, sup-
porting the notion of a replication-associated mechanism [19,23].
These C. elegans studies provide mechanistic insights into POLQ
function and are relevant to studies in mammalian cells, where
a polq deletion induces IR and bleomycin hypersensitivity and
spontaneous micronuclei formation, an indicator of unrepaired
DNA damage during anaphase [27–29]. Similarly overexpression of
POLQ is associated with reduced replication fork speed and
spontaneous chromosomal instability in mammalian cells [30,31].
Thus, POLQ expression likely requires tight regulation to ensure
genome stability.
Chromothripsis, a complex type of chromosomal rearrange-
ments, was recently described to occur in 2–3% of tumor samples
and to be enriched in bone marrow tumors [10]. Chromothripsis
(“chromo” for chromosome and “thripsis” for shattering) is
characterized by often massive, highly localized rearrangements,
likely caused by a shattering of a chromosomal region or chromo-
some followed by DNA fragment ligation in a one-off event [10],
challenging the long-standing idea of progressive mutation accu-
mulation during cancer development. Telomere attrition has been
discussed as one of the possible mechanisms leading to chromo-
thripsis, giving rise to fused chromosomes, which can experience
massive DNA breakage at the cleavage furrow during cytokinesis.
Interestingly, we found that C. elegans mrt-2 mutants defective for
the DNA damage checkpoint and in vivo telomerase activity
grown for generations exhibited increased genomic rearrange-
ments with some evidence of chromothripsis [2]. MRT-2 is the C.
elegans RAD1 subunit of the conserved 9-1-1 DNA damage
checkpoint complex. mrt-2 mutants are defective for the DNA
damage checkpoint and in vivo telomerase activity; telomeres
shorten progressively over generations until the population
succumbs to sterility [32]. Previous studies described the isolation
and initial characterization of stable chromosome fusions from
late generation animals indicating that once telomeres become
critically short, chromosomes engage in end-to-end fusions [32].
Such chromosomal fusions associated with telomere shortening,
using array technology to assess copy number changes, were
linked to fusions that involve replication fork stalling and
template switching processes leading to replication-induced
duplication processes close to the fusion points [33]. Our studies
based on NGS provided examples where two chromosomes with
critically short telomeric sequences undergo a series of breakage
fusion bridge (BFB) cycles followed by a joining event that bears
resemblance to chromothripsis [2]. During BFB cycles, first
postulated by Barbara McClintock in maize, two sister chromatids
fuse in G2 and are ripped apart close to their terminals during cell
division. Such broken chromosomes undergo further cycles of
fusion and breakage [34,35]. The pattern of genomic rearrange-
ments seen in mrt-2 mutants can be explained by several such
BFB cycles, followed by an event involving multiple breaks and
joins, concomitant with the generation of the sequenced fusion
chromosome (Fig. 2B). This final step involving the random
insertion of chromosomal fragments between the two fused
chromosomes is akin to chromothripsis, where large numbers of
chromosomal fragments are randomly assembled [10]. Intrigu-
ingly, a recent study on fusion chromosomes in lymphoblastic
leukemia similarly suggests the presence of initial rounds of
BFB cycles prior to chromosome-to-chromosome fusions with
interstitial insertions of chromosome fragments [36]. Therefore,
the analysis of C. elegans mutants with progressive telomere
shortening combined with cancer mutation profiles support a
contribution of telomere attrition to chromothripsis etiology.
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Fig. 2 – Schematics of DNA repair pathway choice in the repair of G-quadruplex structures and a possible mechanism for the
generation of chromothripsis-like events during telomere attrition. (A) DNA repair pathway choice in the repair of G-quadruplex
structures during replication. Green lines indicate newly synthesized DNA; blue lines represent a homologous DNA sequence.
(B) Generation of chromothripsis-like rearrangements following telomere crisis. Sister chromatid fusions occur at critically short
telomeres. Such fusion chromosomes are ripped apart during the following cell division (red arrows) leading to the gain or loss of
chromosome terminal sequences. Chromosomes that have undergone one or more such breakage-fusion-bridge (BFB) cycles fuse
integrating chromosomal fragments randomly at the fusion sites (K, J, and G in lowest panel), leading to chromothripsis-like
mutation signatures. Gray arrows represent the direction of pulling forces on sister chromatids during anaphase.
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A second mutational signature associated with large genomic
rearrangements is chromoanasynthesis (“chromo” for chromosomes
and “anasynthesis” for reconstitution), a signature predominantly
seen in inherited constitutional genomic disorders. Chromoana-
synthesis is characterized by localized copy number changes invol-
ving DNA sequences from near-by genomic regions with flanking
homology. It likely arises when locally impaired DNA replication
initiates serial microhomology-driven invasions of nearby genomic
regions, often crossing back and forth between regions, thus
converging in chromosomal rearrangement and copy number gains.
Interestingly, exposure of different C. elegans mutant genotypes to
cisplatin and mechlorethamine, chemotherapy drugs used in the
treatment of a broad range of cancers such as sarcoma, lymphoma,
germ cell tumors revealed genomic rearrangements with features of
resembling chromoanasynthesis [2]. Several lines of evidence
suggest that these events are linked to persistent DNA cross-links.
Chromoanasynthesis occurs with both chemically distinct DNA
cross-linking agents, while both agents at the level of single
nucleotide changes lead to distinct signatures, likely associated with
monoadducts. Furthermore, these chromoanasynthesis-like rearran-
gements occur in genomic DNA derived from the clonal progeny of a
zygote formed from single, transiently exposed oocytes and sperm
cells (Fig. 1B). Thus, each cluster, resulting from excessive mis-
templated, localized hyper-replication must have occurred in a
single catastrophic event. Several DNA repair pathways, including
the Fanconi Anemia pathway, double-strand break repair and
translesion synthesis are needed for DNA cross-link repair. Consis-
tent with this, the number and severity of chromoanasynthesis-like
clustered rearrangements was increased in Fanconi Anemia mutants
as well as in xpf-1, which has been discussed to be directly involved
in cross-link repair [37–39]. Such chromoanasynthesis-like events
also occurred in mutants defective in homologous recombination, a
repair modality needed to meld DNA double-strand breaks gener-
ated during DNA cross-link repair. Observing the most severe cases
of chromoanasynthesis in xpf-1 mutants is in line with a reported
overexpression of ERCC1/XPF in cisplatin-resistant cancers. Interest-
ingly, the analysis of cisplatin-induced mutagenesis in various
genetic backgrounds indicates that repair factors, normally asso-
ciated with homologous recombination like SLX-1 and MUS-81
can lead to reduced mutagenesis. Small deletions created by
cisplatin are less frequent in slx-1 and mus-81 mutants [2]. Intrigu-
ingly it also appears that structural rearrangements arise less
frequently in DNA end-joining mutants, in line with earlier reports
that this repair modality might illegitimately join broken chromo-
somes which form as intermediates of DNA cross-link repair [40,41].
In summary, NGS sequencing of C. elegans treated with cisplatin and
analyzed across many DNA repair deficient backgrounds allows to
reconstruct mutation signatures associated with complex chromo-
somal rearrangements in patients. Furthermore, the role of indivi-
dual repair factors can be deduced.
Future directions
New technological developments involving NGS allow for an
understanding of mutational processes at a genome-wide level
and complement classical approaches used for studying DNA
repair processes. For instance, the analysis of DNA breakpoints
in dog-1 and polh-1; polk-1 mutants identified an imprint of the
DNA repair mechanism involved in the generation of deletions
and a subsequent identification of the role of polq-1. Furthermore,
using next generation sequencing, the etiology of complex genetic
rearrangements occurring in hereditary disease and cancer cells
could be mimicked in C. elegans, providing insight into the
relevant mutagenic mechanisms. The systematic analysis of
mutagenesis, occurring in wild-type and DNA repair deficient
backgrounds, with and without DNA damaging agents, will allow
for reconstituting mutational signatures emerging from the
analysis of cancer genomes. Furthermore, important insights into
DNA repair mechanisms, especially those, which are inherently
error prone, will be possible.
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